EU Pharma Wants Staggered Approach For Direct Data Capture In Clinical Trials
Executive Summary
The European pharmaceutical industry feels the European Medicines Agency's recent opinion on the regulatory acceptability of using eSource Direct Data Capture in clinical trials is promising, but that not all EU countries would be ready for its uptake in the near future.
You may also be interested in...
Long-Awaited EU Clinical Trials Portal Meets Major Milestone
A simplified process for registering and evaluating clinical trials promised by the EU Clinical Trial Regulation is finally set to become a reality.
ICH Drafts Modernized Principles For E6 Good Clinical Practice Guide
As part of efforts to “renovate” its good clinical practice (GCP) framework, the International Council for Harmonisation has framed new overarching GCP principles that can be applied to diverse trial types and data sources.
Global Inspection Body To Check Value Of Exchanging Data On ‘Borderline Compliance’ Cases
The 2021 work plan of PIC/S, the international group of pharmaceutical inspectorates, includes renewed efforts to carry out projects that could not be completed due to the coronavirus pandemic.